CNSide Diagnostics logo
Order a Test

LiveLung Webinar to Spotlight Leptomeningeal Metastases with Stanford Neuro-Oncologist Dr. Seema Nagpal

by | Oct 7, 2025 | News

LiveLung will host its monthly patient education webinar, featuring Seema Nagpal, M.D., Neuro-Oncologist at Stanford Health Care, for an in-depth discussion on Leptomeningeal Metastases (LM) — a challenging and often underdiagnosed complication of advanced cancers.

This event offers valuable insights for patients, caregivers, and healthcare providers navigating the complexities of central nervous system (CNS) cancers and their impact on patient outcomes.

Event Details

  • Topic: Leptomeningeal Metastases (LM)
  • Speaker: Seema Nagpal, M.D., Neuro-Oncologist at Stanford Health Care
  • Date & Time: Wednesday, October 8, 2025 — 09:00 AM Eastern (6:00 AM Pacific)
  • How to Watch: Join live or view the recording →

Understanding Leptomeningeal Metastases

Leptomeningeal metastases occur when cancer cells spread to the membranes surrounding the brain and spinal cord, disrupting the central nervous system. LM can affect patients with various advanced cancers, including breast cancer, lung cancer, and melanoma.

Early and accurate detection is critical, as LM often presents with complex neurological symptoms and requires a multidisciplinary approach to treatment and monitoring.

For additional patient-friendly resources and clinical information, visit Learn more about Leptomeningeal Metastases →.

About CNSide® Diagnostics

CNSide® is a proprietary, highly sensitive Cerebrospinal Fluid (CSF) Assay Platform performed in a CLIA-accredited laboratory. Designed for precision detection and monitoring of leptomeningeal metastases and other CNS cancers, CNSide® empowers clinicians with real-time, actionable data to:

  • Support earlier diagnosis of tumor cells in the CSF
  • Monitor disease progression and treatment response over time
  • Guide therapeutic decisions for improved patient outcomes

By enabling smarter, more proactive treatment strategies, CNSide® is advancing the standard of care in neuro-oncology.

Learn More & Stay Connected

Register or watch the recording here: LiveLung LM Webinar
About CNSide® Diagnostics: CNSide Official Website

#LeptomeningealMetastases #LM #CNSideDiagnostics #NeuroOncology #PrecisionDiagnostics #HealthcareInnovation #BrainCancer #CancerResearch #LiveLung #StanfordHealthCare

Written By CNSide Diagnostics

undefined
More Posts by CNSide

Related Posts

Two New Strategic Executive Hires

Dec 9, 2025 |

Expanding operational and regulatory expertise to support commercialization and growth Plus Therapeutics (NASDAQ: PSTV) today announced two key leadership additions to CNSide Diagnostics, its wholly-owned subsidiary, further strengthening the company’s operational...

read more

Houston Business Journal

Dec 5, 2025 |

Strengthening CNS oncology diagnostics at the heart of America’s largest medical ecosystem CNSide Diagnostics, a subsidiary of Plus Therapeutics (NASDAQ: PSTV), has officially expanded into Levit Green, a premier life sciences innovation campus developed by Hines in...

read more

0 Comments